Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TTHX-1114 by Trefoil Therapeutics for Persistent Corneal Epithelial Defects: Likelihood of Approval
TTHX-1114 is under clinical development by Trefoil Therapeutics and currently in Phase I for Persistent Corneal Epithelial Defects. According to...
Data Insights
TTHX-1114 by Trefoil Therapeutics for Herpetic Keratitis: Likelihood of Approval
TTHX-1114 is under clinical development by Trefoil Therapeutics and currently in Phase I for Herpetic Keratitis. According to GlobalData, Phase...